Colin Aitken is a Senior Specialist in Operations at Merck, overseeing processes for HPV Alum and buffer workflows while managing a team of 16 employees. Prior roles at Merck include managing COVID vaccine operations and engineering technical operations aimed at optimizing aseptic manufacturing equipment. Previous experience includes product development engineering at ActiveProtective, where Colin managed production operations for a wearable airbag safety device, and contract engineering at BD, contributing to the development and reliability enhancement of wearable injectors. Colin holds a Master's Degree in Systems Engineering and a Bachelor's Degree in Biomedical Engineering, both from Stevens Institute of Technology.
January, 2024 - present
June, 2022
March, 2020